![Arnaud Foussat](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Arnaud Foussat
Directeur Général chez Yukin Therapeutics SAS
Profil
Arnaud Foussat is currently the Chief Executive Officer at Yukin Therapeutics SAS and the Chairman at Alderaan Biotechnology SAS.
Previously, he worked as the Principal at Institut National de la Santé & de la Recherche Médicale and as the Chief Scientific Officer & Vice President at Sangamo Therapeutics France SAS.
Dr. Foussat holds an undergraduate degree from the University of Strasbourg and a doctorate degree from Université Paris Diderot-Paris 7.
Postes actifs de Arnaud Foussat
Sociétés | Poste | Début |
---|---|---|
Alderaan Biotechnology SAS
![]() Alderaan Biotechnology SAS BiotechnologyHealth Technology Alderaan Biotechnology SAS operates as preclinical stage firm, that develops monoclonal antibodies for the treatment of cancer. The company was founded by Daniel Olive and Armand Bensussan on July 17, 2017 and is headquartered in Paris, France. | Président | - |
Yukin Therapeutics SAS
![]() Yukin Therapeutics SAS Pharmaceuticals: MajorHealth Technology Yukin Therapeutics SAS manufactures pharmaceutical preparations. The company was founded by Matthieu Coutet on June 29, 2018 and is headquartered in Paris, France. | Directeur Général | 01/06/2018 |
Anciens postes connus de Arnaud Foussat
Sociétés | Poste | Fin |
---|---|---|
TXCELL | Directeur Technique/Scientifique/R&D | 01/03/2017 |
Institut National de la Santé & de la Recherche Médicale
![]() Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Corporate Officer/Principal | - |
Formation de Arnaud Foussat
University of Strasbourg | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 5 |
---|---|
Institut National de la Santé & de la Recherche Médicale
![]() Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Commercial Services |
Université Paris Diderot-Paris 7 | Consumer Services |
Sangamo Therapeutics France SAS
![]() Sangamo Therapeutics France SAS Miscellaneous Commercial ServicesCommercial Services Sangamo Therapeutics France SAS is a biotechnology company, which engages in developing platforms for T cell immunotherapies for the treatment of severe inflammatory and autoimmune diseases. The company was founded on April 12, 2001, and is headquartered in Valbonne-Sophia Antipolis, France. | Commercial Services |
Yukin Therapeutics SAS
![]() Yukin Therapeutics SAS Pharmaceuticals: MajorHealth Technology Yukin Therapeutics SAS manufactures pharmaceutical preparations. The company was founded by Matthieu Coutet on June 29, 2018 and is headquartered in Paris, France. | Health Technology |
Alderaan Biotechnology SAS
![]() Alderaan Biotechnology SAS BiotechnologyHealth Technology Alderaan Biotechnology SAS operates as preclinical stage firm, that develops monoclonal antibodies for the treatment of cancer. The company was founded by Daniel Olive and Armand Bensussan on July 17, 2017 and is headquartered in Paris, France. | Health Technology |